Chemomab jumps on positive liver scarring trial results
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
Chemomab Therapeutics (Nasdaq: CMMB), which is developing treatments for fibro-inflammatory (scarring) diseases, rose 14% on Friday and is up...
The non-invasive ultrasound treatment will be offered to 20 hospital patients free of charge over the next two years as...
The global neurology market size was estimated at USD 3.32 billion in 2023 and is projected to hit around USD...
Winners to receive $10,000 honorary donation to a health charity of their choice, courtesy of Echosens PARIS, Aug. 26, 2024...
The Inequalities in Health Alliance (IHA) is a coalition of more than 250 organisations, convened by the RCP, which campaigns...
Publishing their work in the Proceedings of the National Academy of Sciences, Vibhor Krishna, MD, at the UNC School of...